As reduced nuclear levels of TDP-43 are caused by ALS/FTD-associated mutations and endothelial barrier defects, we propose the TDP-43 alterations within the endothelium contribute to BBB permeability and cognitive dysfunction in ALS/FTD, and perhaps other diseases where TDP-43 dysfunction has been reported. This evidence concerns the gene TARDBP and frontotemporal dementia.